Bath & Body Works (NYSE:BBWI) Price Target Raised to $25.00

Bath & Body Works (NYSE:BBWI) had its price objective increased by research analysts at Wells Fargo & Company from $24.00 to $25.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 11.92% from the stock’s current price.

Several other research firms have also recently weighed in on BBWI. Robert W. Baird reduced their price objective on Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a research report on Thursday, August 27th. Jefferies Financial Group upped their target price on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. JPMorgan Chase & Co. increased their price target on shares of Bath & Body Works from $22.00 to $24.00 and gave the company a “neutral” rating in a report on Tuesday, August 18th. Deutsche Bank Aktiengesellschaft set a $22.00 price target on shares of Bath & Body Works in a research report on Thursday, August 27th. Finally, UBS Group dropped their price objective on shares of Bath & Body Works from $19.00 to $17.00 and set a “neutral” rating on the stock in a report on Thursday, August 27th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $22.20.

Bath & Body Works Price Performance

Shares of BBWI opened at $22.34 on Thursday. The company has a market capitalization of $4.50 billion, a PE ratio of 5.85, a price-to-earnings-growth ratio of 1.05 and a beta of 1.40. Bath & Body Works has a one year low of $14.27 and a one year high of $25.21. The company’s fifty day moving average price is $18.44 and its 200 day moving average price is $19.85.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.38. The company had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The business’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Analysts anticipate that Bath & Body Works will post 2.73 earnings per share for the current year.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently modified their holdings of the stock. BlackRock Inc. bought a new position in shares of Bath & Body Works during the 2nd quarter worth approximately $449,065,000. Bank of America Corp DE bought a new position in shares of Bath & Body Works during the second quarter valued at $62,249,000. Bank of New York Mellon Corp bought a new position in shares of Bath & Body Works during the second quarter valued at $59,260,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Bath & Body Works by 34.2% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company’s stock valued at $51,857,000 after acquiring an additional 707,449 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in shares of Bath & Body Works by 885.7% in the 1st quarter. Renaissance Technologies LLC now owns 2,732,733 shares of the company’s stock valued at $51,020,000 after purchasing an additional 2,455,500 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its merchandise includes body lotions, shower gels, fragrances, soaps, hand sanitizers, candles, air fresheners and other fragrance-focused items sold under the Bath & Body Works brand.

The company operates through a network of retail stores and digital commerce channels, serving customers primarily in the United States and Canada. Its products are also available internationally through select partners, including franchise, wholesale and other distribution arrangements.

Bath & Body Works traces its origins to 1990 and was formerly part of L Brands, Inc The company became an independent publicly traded business in 2021 after separating from L Brands.